Neurol. pro Praxi, 2005; 5: 245-247

Komorbidita a cievne mozgové príhody

doc. MUDr. Zuzana Gdovinová CSc
Neurologická klinika LF UPJŠ a FNsP, Košice

Cievne mozgové príhody (CMP) sú hlavnou získanou príčinou zneschopnenia a 3. najčastejšou príčinou smrti u dospelej populácie. Úspešnosť liečby v akútnom štádiu, prevencia recidívy ochorenia, následná kvalita života ako aj úmrtnosť však nezávisia len od liečby, ale výrazný podiel na prognóze pacienta má aj komorbidita a jej liečba. Komorbidita je definovaná ako výskyt ďalšieho koexistujúceho ochorenia. Presnejšie, komorbidita je považovaná za asociáciu medzi 2 ochoreniami, ktorá je viac ako koincidentálna. Vo vzťahu k CMP sú ako komorbiditné najčastejšie kardiovaskulárne ochorenia – infarkt myokardu, resp. ochorenie koronárnych ciev, fibrilácia predsiení, arteriálna hypertenzia, ďalej diabetes mellitus, poruchy metabolizmu lipidov, migréna, depresia, epilepsia, z hľadiska liečby je potrebné zohľadniť liekové interakcie pri liečbe vertebrogénnych ochorení.

Keywords: Kľúčové slová: cievne mozgové príhody, infarkt myokardu, fibrilácia predsiení, arteriálna hypertenzia, migréna, vertebrogénne ochorenia.

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gdovinová Z. Komorbidita a cievne mozgové príhody. Neurol. praxi. 2005;6(5):245-247.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. American Heart Association, Inc. ICPC-2 Category K. Circulatory. Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke. Circulation 2003; 108: 1278. Go to original source... Go to PubMed...
    2. Ansell J, Hirsch J, Wenger NK. Warfarin dosing guidelines. Endorsed by the Anticoagulation Forum and the AHA Council on Atherosclerosis, Thrombosis, and Vascular Biology. October 1999.
    3. Bell DSH. Stroke in diabetic patient. Diabetes Care 1994; 17: 213-219. Go to original source... Go to PubMed...
    4. Cífková R, Horký K, Widimský J sr, Widimský J jr, Filipovský M, Grundmann M, Monhart V, Rosolová H, Souček M, Špinar J, Vítovec J. Doporučení České společnosti pro hypertenzi. www.kardiologickarevue.cz, ročník 2005, číslo 1.
    5. Ezekowitz MD, Levine JA. Preventing stroke in patients with atrial fibrillation. JAMA 1999; 281: 1830-1835. Go to original source... Go to PubMed...
    6. Gdovinová Z, Veselá D, Eiben E. Súčasný stav diagnostiky cievnych mozgových príhod a nevyhnutné smery jej zlepšenia. Folia Medica Cassoviensa 1998; 56: 156-159.
    7. Goldstein LB, Samsa GP, Matchar DB, Horner RD. Charlson Index Comorbidity Adjustment for Ischemic Stroke Outcome Studies. Stroke 2004; 35: 1941-1945. Go to original source... Go to PubMed...
    8. Hart RG, Benavente O, McBridge R, et al. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: analysis of pooled data from five randomized controlled trials. Archives of Internal medicine 1999; 131: 492-501. Go to original source... Go to PubMed...
    9. http://circ.ahajournals.org/cgi/content/full/108/10/1278
    10. Jorgensen HS, Nakayama H, Christensen HR, et al. Blood Presure in acute stroke. Cerebrovascular Diseases 2002; 13: 204-209. Go to original source... Go to PubMed...
    11. Judd LL, Kunovac JL. Clinical Characteristics and Management of Unipolar Depressive Disorders Comorbid with Neurological Disorders. Neuropsychobiology 1998; 37: 84-87. Go to original source... Go to PubMed...
    12. Laguna P, Martín A, del Arco C, et al. Risk factors for stroke and tromboprophylaxis in atrial fibrillation: What happens in daily clinical practice? The GEFAUR-1 Study. Annals of Emergency Medicine 2004; 44: 3-11. Go to original source...
    13. Miller VT, Rothrock JF, Pearce LA, et al. Ischemic stroke in patients with atrial fibrillation according to stroke mechanism. Stroke Prevention in Atrial Fibrillation Investigators. Neurology 1993; 43: 32-36. Go to original source... Go to PubMed...
    14. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop. Neurology 1993; 43: 250-260. Go to original source... Go to PubMed...
    15. Sacco RL, Benson RT, Kargman DE, et al. High-Density lipoprotein cholesterol and ischemic Stroke in the Elderly. The Northern Manhattan Stroke Study. JAMA 2001; 21: 2729-2735. Go to original source... Go to PubMed...
    16. Tzourio C, Iglésias S, Hubert BJ, et al. Migraine and risk of ischaemic stroke. BMJ 1993; 307: 289-292. Go to original source... Go to PubMed...
    17. Wolf PA, Abbot R, Kannel WB, et al. Atrial fibrillation as an independent risk factor for stroke: The Framingham study stroke 1991; 22: 983-987.

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.